CME Accredited CLL Course
Course 1: Why is genomic testing important in CLL and what does it mean for patients?
Toby Eyre, MBChB (Hons), MRCP (UK), FRCPath (UK), MD
Prioty Islam, MD, MSc
Matthew Davids, MD, MMSc
Lydia Scarfò, MD
Watch Time: 65 minutes
(1) CME Credit
Learn about the need for and importance of genomic testing in chronic lymphocytic leukemia, including the prognostic and predictive value of TP53 aberrations and IGHV mutational status.